Tumor-associated antigens provoke a tumor-specific immune response, leading to activation of MHC class I-restricted CD8+ T cells and MHC class II-restricted CD4+ T cells, with the latter exerting essential regulatory and effector roles in antitumor immunity [35]. Here, CD8A is linked to neoplasm.